Literature DB >> 33531391

MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection.

Ekaterina Marakasova1, Ancha Baranova2.   

Abstract

Entities:  

Year:  2021        PMID： 33531391     DOI： 10.1128/mBio.03447-20

Source DB:  PubMed          Journal:  mBio            Impact factor:   7.867


× No keyword cloud information.
  9 in total

1.  A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella.

Authors:  Manlio Fusciello; Erkko Ylösmäki; Sara Feola; Arttu Uoti; Beatriz Martins; Karri Aalto; Firas Hamdan; Jacopo Chiaro; Salvatore Russo; Tapani Viitala; Vincenzo Cerullo
Journal:  Mol Ther Oncolytics       Date:  2022-04-19       Impact factor: 6.311

2.  Does the rubella immunoglobulin G affect the severity of COVID- 19?  : Rubella immunoglobulin G and COVID- 19.

Authors:  Leyla Sahebi; Mohsen Hosseini; Alireza Abdollahi; Nahid Farrokhzad; Samrand Fattah Ghazi; Farzaneh Samaei Noroozi; Fereshteh Ghiasvand
Journal:  BMC Microbiol       Date:  2022-06-11       Impact factor: 4.465

3.  SARS-CoV-2 spike protein displays sequence similarities with paramyxovirus surface proteins; a bioinformatics study.

Authors:  Ehsan Ahmadi; Mohammad Reza Zabihi; Ramin Hosseinzadeh; Leila Mohamed Khosroshahi; Farshid Noorbakhsh
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

Review 4.  Why Does the Severity of COVID-19 Differ With Age?: Understanding the Mechanisms Underlying the Age Gradient in Outcome Following SARS-CoV-2 Infection.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Pediatr Infect Dis J       Date:  2022-02-01       Impact factor: 3.806

5.  Effectiveness of booster BCG vaccination in preventing Covid-19 infection.

Authors:  Lradj Amirlak; Rifat Haddad; John Denis Hardy; Naief Suleiman Khaled; Michael H Chung; Bardia Amirlak
Journal:  Hum Vaccin Immunother       Date:  2021-08-17       Impact factor: 3.452

6.  COVID-19 susceptibility and vaccination coverage for measles, rubella and mumps in students and healthcare workers in Trieste hospitals (NE Italy).

Authors:  Eleonora Cattaruzza; Lucia Radillo; Federico Ronchese; Corrado Negro; Francesca Rui; Paola De Michieli; Francesca Larese Filon
Journal:  Vaccine X       Date:  2022-02-25

7.  A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.

Authors:  Yuexiu Zhang; Mijia Lu; K C Mahesh; Eunsoo Kim; Mohamed M Shamseldin; Chengjin Ye; Piyush Dravid; Michelle Chamblee; Jun-Gyu Park; Jesse M Hall; Sheetal Trivedi; Supranee Chaiwatpongsakorn; Adam D Kenny; Satyapramod Srinivasa Murthy; Himanshu Sharma; Xueya Liang; Jacob S Yount; Amit Kapoor; Luis Martinez-Sobrido; Purnima Dubey; Prosper N Boyaka; Mark E Peeples; Jianrong Li
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-27       Impact factor: 12.779

8.  Presumed Protective Role for Anti-Hepatitis B Virus Antibodies Against COVID-19 Severe Cases: A Clinical Study Confirming in silico Hypothesis.

Authors:  Mariem Gdoura; Raoua Touati; Sana Kalthoum; Rania Ben Slama; Nouel Fatnassi; Mehdi Mrad; Lamia Ammari; Nozha Brahmi; Amira Ben Jazia; Nahed Hogga; Henda Triki; Sondes Haddad-Boubaker
Journal:  Front Med (Lausanne)       Date:  2022-07-08

9.  Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naïve individuals.

Authors:  Mariliis Jaago; Annika Rähni; Nadežda Pupina; Arno Pihlak; Helle Sadam; Jürgen Tuvikene; Annela Avarlaid; Anu Planken; Margus Planken; Liina Haring; Eero Vasar; Miljana Baćević; France Lambert; Eija Kalso; Pirkko Pussinen; Pentti J Tienari; Antti Vaheri; Dan Lindholm; Tõnis Timmusk; Amir M Ghaemmaghami; Kaia Palm
Journal:  Sci Rep       Date:  2022-10-07       Impact factor: 4.996
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.